DK0624574T3 - Hidtil ukendte prostaglandinanaloger - Google Patents

Hidtil ukendte prostaglandinanaloger

Info

Publication number: DK0624574T3
Authority: DK; Denmark
Prior art keywords: hitherto unknown; prostaglandin analogues; prostaglandin; analogues; hitherto
Prior art date: 1989-10-16

Application number

DK94111337T

Other languages

Danish (da)

English (en)

Inventor

Toshihide C O Seikagak Inomata

Arata Yasuda

Yutaka Mizushima

Original Assignee

Seikagaku Kogyo Co Ltd

Yoshitomi Pharmaceutical

Asahi Glass Co Ltd

Yutaka Mizushima

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-16

Filing date

1990-10-15

Publication date

1999-10-25

1990-10-15 Application filed by Seikagaku Kogyo Co Ltd, Yoshitomi Pharmaceutical, Asahi Glass Co Ltd, Yutaka Mizushima filed Critical Seikagaku Kogyo Co Ltd

1999-10-25 Application granted granted Critical

1999-10-25 Publication of DK0624574T3 publication Critical patent/DK0624574T3/da

Links

229940006138 antiglaucoma drug and miotics prostaglandin analogues Drugs 0.000 title 1
150000003180 prostaglandins Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Nanotechnology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Crystallography & Structural Chemistry (AREA)
Dispersion Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Cosmetics (AREA)

DK94111337T 1989-10-16 1990-10-15 Hidtil ukendte prostaglandinanaloger DK0624574T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP1266230A JP2602964B2 (ja)	1989-10-16	1989-10-16	プロスタグランジン類縁体およびその脂肪乳剤

Publications (1)

Publication Number	Publication Date
DK0624574T3 true DK0624574T3 (da)	1999-10-25

Family

ID=17428079

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK94111337T DK0624574T3 (da)	1989-10-16	1990-10-15	Hidtil ukendte prostaglandinanaloger
DK90119772.3T DK0423697T3 (da)	1989-10-16	1990-10-15	Lipidemulsion indeholdende en prostaglandinanalog

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK90119772.3T DK0423697T3 (da)	1989-10-16	1990-10-15	Lipidemulsion indeholdende en prostaglandinanalog

Country Status (10)

Country	Link
US (1)	US5120870A (fr)
EP (2)	EP0423697B1 (fr)
JP (1)	JP2602964B2 (fr)
AT (2)	ATE117989T1 (fr)
AU (1)	AU641436B2 (fr)
CA (1)	CA2027351C (fr)
DE (2)	DE69033069T2 (fr)
DK (2)	DK0624574T3 (fr)
ES (2)	ES2070238T3 (fr)
GR (2)	GR3015963T3 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2158350A1 (fr) *	1994-01-18	1995-07-20	Toru Minoshima	7-thiaprostaglandines et methode de production connexe
WO1999009992A1 (fr) *	1997-08-27	1999-03-04	Yoshitomi Pharmaceutical Industries, Ltd.	Promoteurs de neovascularisation
DE69939826D1 (de)	1998-06-04	2008-12-11	Ltt Bio Pharma Co Ltd	Verfahren zur herstellung eines gereinigten prostaglandin-derivats
US20050048126A1 (en)	2000-12-22	2005-03-03	Barrett Rabinow	Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
MXPA04002446A (es)	2001-09-26	2004-07-23	Baxter Int	Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
JP2003342196A (ja) *	2002-05-31	2003-12-03	Mukku:Kk	静脈注射用組成物、その製造法およびその製剤
JP2007520555A (ja) *	2004-02-05	2007-07-26	バクスター・インターナショナル・インコーポレイテッド	自己安定化剤の使用により調製された分散剤
EP1655021B1 (fr)	2004-11-09	2008-10-29	Novagali Pharma SA	Emulsion huile-dans-eau à basse concentration de l'agent cationique et au potentiel de zéta positif
CA2578176C (fr) *	2004-11-09	2013-09-24	Novagali Pharma Sa	Emulsions ophtalmiques renfermant un agent immuno-suppressif
CN101282714B (zh) *	2005-10-10	2012-12-12	诺瓦加利制药公司	包含前列腺素的眼用乳剂
RU2470644C2 (ru)	2006-09-05	2012-12-27	Кью.Пи. КОПЭРЕЙШН	Стабильная жировая эмульсия (варианты), способ ее получения, эмульгирующий агент и способы стабилизации простагландина и капель жира
US8722736B2 (en)	2007-05-22	2014-05-13	Baxter International Inc.	Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en)	2007-05-22	2013-04-23	Baxter International Inc.	Colored esmolol concentrate
EP2228058A1 (fr)	2009-03-04	2010-09-15	Novagali Pharma S.A.	Émulsion anionique d'huile dans l'eau contenant des prostaglandines et leurs utilisations
EP2389939A1 (fr)	2010-05-28	2011-11-30	Novagali Pharma S.A.	Utilisation de prostaglandines F2alpha et analogues pour la cicatrisation des lésions de la cornée et du conjonctif
WO2012021107A2 (fr)	2010-08-12	2012-02-16	Nanyang Technological University	Formulation de liposomes pour l'administration d'un médicament dans l'œil
US9956195B2 (en)	2014-01-07	2018-05-01	Nanyang Technological University	Stable liposomal formulations for ocular drug delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4363817A (en) *	1981-08-27	1982-12-14	Miles Laboratories, Inc.	Enol acylate analogs of E1 and E2 prostaglandins
JPS58222014A (ja) *	1982-06-18	1983-12-23	Taisho Pharmaceut Co Ltd	プロスタグランジンｅ↓１脂肪乳剤
JPS59216820A (ja) *	1983-05-20	1984-12-06	Taisho Pharmaceut Co Ltd	プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) *	1984-01-12	1996-02-28	株式会社ミドリ十字	脂肪乳剤中のプロスタグランジンの安定化方法
DE3421468A1 (de) *	1984-06-08	1985-12-19	Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim	Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPS61151126A (ja) *	1984-12-25	1986-07-09	Teijin Ltd	△７―プロスタグランジンａ１類を有効成分として含有する注射用の脂肪乳剤

1989
- 1989-10-16 JP JP1266230A patent/JP2602964B2/ja not_active Expired - Lifetime
1990
- 1990-10-12 US US07/597,870 patent/US5120870A/en not_active Expired - Lifetime
- 1990-10-12 AU AU64526/90A patent/AU641436B2/en not_active Ceased
- 1990-10-15 AT AT90119772T patent/ATE117989T1/de not_active IP Right Cessation
- 1990-10-15 DK DK94111337T patent/DK0624574T3/da active
- 1990-10-15 ES ES90119772T patent/ES2070238T3/es not_active Expired - Lifetime
- 1990-10-15 DK DK90119772.3T patent/DK0423697T3/da active
- 1990-10-15 EP EP90119772A patent/EP0423697B1/fr not_active Expired - Lifetime
- 1990-10-15 EP EP94111337A patent/EP0624574B1/fr not_active Expired - Lifetime
- 1990-10-15 ES ES94111337T patent/ES2132279T3/es not_active Expired - Lifetime
- 1990-10-15 DE DE69033069T patent/DE69033069T2/de not_active Expired - Fee Related
- 1990-10-15 DE DE69016567T patent/DE69016567T2/de not_active Expired - Fee Related
- 1990-10-15 CA CA002027351A patent/CA2027351C/fr not_active Expired - Lifetime
- 1990-10-15 AT AT94111337T patent/ATE179169T1/de not_active IP Right Cessation
1995
- 1995-04-28 GR GR950401086T patent/GR3015963T3/el unknown
1999
- 1999-07-07 GR GR990401801T patent/GR3030718T3/el unknown

Also Published As

Publication number	Publication date
ES2132279T3 (es)	1999-08-16
JP2602964B2 (ja)	1997-04-23
EP0624574A3 (fr)	1995-01-18
ES2070238T3 (es)	1995-06-01
ATE117989T1 (de)	1995-02-15
DE69016567D1 (de)	1995-03-16
AU6452690A (en)	1991-04-18
EP0423697A3 (en)	1992-08-05
JPH03204853A (ja)	1991-09-06
CA2027351A1 (fr)	1991-04-17
EP0624574B1 (fr)	1999-04-21
DK0423697T3 (da)	1995-05-29
AU641436B2 (en)	1993-09-23
EP0423697A2 (fr)	1991-04-24
US5120870A (en)	1992-06-09
GR3015963T3 (en)	1995-07-31
DE69016567T2 (de)	1995-09-21
ATE179169T1 (de)	1999-05-15
EP0423697B1 (fr)	1995-02-01
DE69033069T2 (de)	1999-08-19
CA2027351C (fr)	2001-06-19
EP0624574A2 (fr)	1994-11-17
GR3030718T3 (en)	1999-11-30
DE69033069D1 (de)	1999-05-27

Publication	Publication Date	Title
ATE179169T1 (de)	1999-05-15	Prostaglandinanaloge
MX9203338A (es)	1992-09-01	Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
ATE21105T1 (de)	1986-08-15	7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
DK0398283T3 (da)	1994-11-28	Stimulatoriske aminosyreantagonister
NO894349L (no)	1990-05-03	Tienopyridin-type mevalonolaktoner.
PT87537A (pt)	1989-05-31	Process for the preparation of cyclic anticoagulant peptides
PT87536A (pt)	1989-05-31	Process for the preparation of cyclic anticoagulant peptides
ZA905505B (en)	1991-04-24	Hemoregulatory peptides
DE68916850D1 (de)	1994-08-25	Antikoagulierende Peptid-Alkohole.
IT8819603A0 (it)	1988-03-01	Analoghi della ammino prostaglandina 7 ossabicicloeptansostituiti.
FI901277A0 (fi)	1990-03-14	2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ES2053707T3 (es)	1994-08-01	Procedimiento para la preparacion de amidas de acidos 3,3-diaril-acrilicos.
ATE60779T1 (de)	1991-02-15	N-glykolylneuraminsaeurederivat.
DE3470312D1 (de)	1988-05-11	Ether of n-propanolamine derivative
ES2089176T3 (es)	1996-10-01	Procedimiento para la preparacion de carboditioatos de piperidina fluorometil-sustituidos.
DK656889D0 (da)	1989-12-21	Hidtil ukendte forbindelser
DK36689D0 (da)	1989-01-27	Fremgangsmaade til fremstilling af et 16-methoxy-16-methyl-prostaglandin e1-derivat, samt ved fremgangsmaaden anvendelige mellemprodukter
ES515094A0 (es)	1983-10-16	Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina.
ATE66459T1 (de)	1991-09-15	Herstellungsverfahren von trifluormethylverbindungen.
FI873000A0 (fi)	1987-07-07	Substituoituja 1,2,3-tiadiatsoli-4-tiolaatteja